We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
56 hedge funds and large institutions have $62.8M invested in Corcept Therapeutics in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
56% less call options, than puts
Call options by funds: $75K | Put options by funds: $172K
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
$75K
Puts
$172K
Net Calls
-$97K
Net Calls Change
-$97K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| $5K | +$5.33K | +2,967 | New |
|
|
BG
52
BlackRock Group
London,
United Kingdom
| $4K | +$4.31K | +2,397 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $3K | +$3.6K | +2,000 | New |
|
54
BlackRock
New York
| $1K | +$1.45K | +805 | New |
|
55
Citigroup
New York
| – | +$126 | +70 | New |
|
|
RFC
56
Russell Frank Company
Seattle,
Washington
| – | +$502 | +279 | New |
|
CORT Hedge Fund Activity: Q2 2013 in Review
56 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q2 2013, worth a combined $62.8M.
Buyers outnumbered sellers: 56 funds opened new CORT positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.
- 56 institutional investors held Corcept Therapeutics (CORT) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $62.8M of Corcept Therapeutics stock for Q2 2013.
- 56 funds opened new Corcept Therapeutics positions in Q2 2013 and 0 closed out, a net change of +56 holders.
Based on aggregated 13F filings for Q2 2013.